Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T07137
|
||||
Former ID |
TTDS00314
|
||||
Target Name |
4-hydroxyphenylpyruvate dioxygenase
|
||||
Gene Name |
HPD
|
||||
Synonyms |
4HPPD; F Alloantigen; F protein; HPPDase; HPD
|
||||
Target Type |
Successful
|
||||
Disease | Hereditary tyrosinemia type 1 [ICD9: 270.2; ICD10: E70.2] | ||||
Respiratory syncytial virus infection [ICD9: 79.6; ICD10: B97.4] | |||||
Function |
Key enzyme in the degradation of tyrosine.
|
||||
BioChemical Class |
Oxidoreductases acting on single donors
|
||||
Target Validation |
T07137
|
||||
UniProt ID | |||||
EC Number |
EC 1.13.11.27
|
||||
Sequence |
MTTYSDKGAKPERGRFLHFHSVTFWVGNAKQAASFYCSKMGFEPLAYRGLETGSREVVSH
VIKQGKIVFVLSSALNPWNKEMGDHLVKHGDGVKDIAFEVEDCDYIVQKARERGAKIMRE PWVEQDKFGKVKFAVLQTYGDTTHTLVEKMNYIGQFLPGYEAPAFMDPLLPKLPKCSLEM IDHIVGNQPDQEMVSASEWYLKNLQFHRFWSVDDTQVHTEYSSLRSIVVANYEESIKMPI NEPAPGKKKSQIQEYVDYNGGAGVQHIALKTEDIITAIRHLRERGLEFLSVPSTYYKQLR EKLKTAKIKVKENIDALEELKILVDYDEKGYLLQIFTKPVQDRPTLFLEVIQRHNHQGFG AGNFNSLFKAFEEEQNLRGNLTNMETNGVVPGM |
||||
Drugs and Mode of Action | |||||
Inhibitor | (4-Hydroxy-phenoxy)-acetic acid | Drug Info | [526361] | ||
2-(2-Bromo-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-(2-Chloro-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-(2-Iodo-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-(2-Methoxy-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-(2-Methyl-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-(2-Nitro-benzoyl)-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-acetyl-3-hydroxycyclohex-2-enone | Drug Info | [528436] | |||
2-Acetyl-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-Cyclopropanecarbonyl-cyclohexane-1,3-dione | Drug Info | [525791] | |||
2-Propionyl-cyclohexane-1,3-dione | Drug Info | [525791] | |||
3-hydroxy-2-propionylcyclohex-2-enone | Drug Info | [528436] | |||
3-Hydroxy-4-phenyl-5H-furan-2-one | Drug Info | [526361] | |||
Acetate Ion | Drug Info | [551393] | |||
BMS-433771 | Drug Info | [537350] | |||
Diketonitrile | Drug Info | [535880] | |||
Nitisinone | Drug Info | [535880], [536692] | |||
Pathways | |||||
References | |||||
Ref 525791 | Bioorg Med Chem Lett. 2000 May 1;10(9):843-5.SAR studies of 2-o-substituted-benzoyl- and 2-alkanoyl-cyclohexane-1,3-diones as inhibitors of 4-hydroxyphenylpyruvate dioxygenase. | ||||
Ref 526361 | Bioorg Med Chem Lett. 2002 Jul 8;12(13):1709-13.Design, synthesis, and evaluation of postulated transient intermediate and substrate analogues as inhibitors of 4-hydroxyphenylpyruvate dioxygenase. | ||||
Ref 528436 | Bioorg Med Chem Lett. 2006 Dec 1;16(23):6024-7. Epub 2006 Sep 18.Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced conformation-restricted cyclopropanecarbonyl derivatives. | ||||
Ref 535880 | 4-Hydroxyphenylpyruvate dioxygenase as a drug discovery target. Drug News Perspect. 2003 Oct;16(8):493-6. | ||||
Ref 536692 | Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother. 2008 May;9(7):1229-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.